Article Listing - Bayer initiates Ph III trail of Xarelto in cardiac event prevention; R&D day presentation

EAST GERMAN FIRMS ASSERT THEMSELVES

13 April 1992

The 30 member companies of the eastern German section of the German drug industry association, the BPI, increased their share...

US FDA APPROVES ABBOTT BLOOD TEST

13 April 1992

The US Food and Drug Administ-ration has approved Abbott Labor-atories' Abbott TDx Cyclosporine Monoclonal Whole Blood Assay, an automated monoclonal...

WORLD NEWS IN BRIEF

13 April 1992

- Indonesia will supply condoms and other contraceptives to Vietnam to support the country's family planning program, reports the Voice...

US PMA SUIT AGAINST ARKANSAS

13 April 1992

The US Pharmaceutical Manufact-urers Association has filed suit against Arkansas' new Medicaid prior-authorization program, claiming it violates state laws and...

BAYER JAPAN PROFITS BOOST

13 April 1992

The Bayer group in Japan, which consists of 15 companies, was able to increase its sales by 1.7% to 219.5...

SUPPORT FOR CANADIAN CENTER

13 April 1992

One of the problems that Canada's pharmaceutical industry has is that it is dominated by foreign companies which do not...

NEW EURO CHAIRMAN AT SMITHKLINE BEECHAM

13 April 1992

Charles Woler has been appointed chairman of the Europ-ean pharmaceutical operations of SmithKline Beecham. He succeeds Martyn Greenacre, who is...

APPOINTMENTS AT AKZO

13 April 1992

Lodewijk van Wachem and Abraham Cohen have been elected to the supervisory board of Akzo NV in the Netherlands.

GROWING EC MARKET FOR HOMEOPATHY

13 April 1992

Addressing the rapid growth which the herbal medicines industry has experienced globally in recent years, international management consultant McAlpine Thorpe...

BEIERSDORF SEES SALES AND PROFIT UP

13 April 1992

Profits at the north German drugs group Beiersdorf AG have incr-eased at an above-average rate in relation to good sales...

Showing 94261-94270 of 95337 articles